MeNZB – a gift we didn’t expect, and are still unwrapping

+Print Archive
Vaccines

MeNZB – a gift we didn’t expect, and are still unwrapping

Helen Petousis-Harris

Helen Petousis-Harris

MeNZB multi
A gift: the MeNZB vaccine was more broadly effective than expected

The 2004–2008 MeNZB meningococcal vaccine programme reached over one million adolescents; an epidemic was curtailed and a legacy set up for reduced rates of gonorrhoea

By Helen Petousis-Harris  The second most common bacterial sexually transmitted disease, gonorrhoea, has officially become a superbug, with multidr
References

1. Petousis-Harris H, Paynter J, Morgan J et al. Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study. Lancet 7 Jul 2017. doi: 10.1016/S0140-6736(17)31449-6. [Epub]

2. Pérez O, Campo JD, Cuello M et al. Mucosal approaches in Neisseria vaccinology. VacciMonitor 2009;18(2):53–55.